Mankind Pharma to roll out cheapest coronavirus drug
Mankind Pharma to roll out cheapest coronavirus drug The full treatment of Molulife (brand name) is expected to cost ₹1,400, RC Juneja, chairman of Mankind Pharma, told ET. The brand is expected to hit this week in the market, he said. https://ift.tt/eA8V8J
The toll of the unvaccinated in hospitals continues to rise, compromising life-saving care for those in need
The toll of the unvaccinated in hospitals continues to rise, compromising life-saving care for those in need
https://ift.tt/32DyQJT January 04, 2022 at 02:01AM https://ift.tt/1R552o9
 |
submitted by /u/RichKatz [link] [comments] |
Reduce your biological age and increase your healthspan. Rejuvant wants to help you defy the aging process and say ‘yes’ to a longer, healthier life.
Reduce your biological age and increase your healthspan. Rejuvant wants to help you defy the aging process and say ‘yes’ to a longer, healthier life.
https://ift.tt/3pPjMkT January 03, 2022 at 11:34PM https://ift.tt/1R552o9
 |
submitted by /u/philnewman100 [link] [comments] |
Omicron variant: Health experts are concerned about possible rise in hospitalisation
Omicron variant: Health experts are concerned about possible rise in hospitalisation Some people will require hospitalisation and oxygen, but even they are “unlikely to require ventilators”, he said. https://ift.tt/eA8V8J
Covid cases on the rise, experts call for newer drugs, faster approvals
Covid cases on the rise, experts call for newer drugs, faster approvals The Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moderate Covid-19 at high risk of developing into severe disease. https://ift.tt/eA8V8J
Subscribe to:
Posts (Atom)
Popular Posts
|
